We are live on
!
Find out more
DCM
DAFNA Capital Management Portfolio holdings
AUM
$440M
1-Year Est. Return
109.12%
This Fund
S&P 500
This Quarter
Est. Return
-4.59%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$99.1M
AUM Growth
-$6.37M
(-6%)
Cap. Flow
+$1.03M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
58.86%
Holding
65
New
16
Increased
6
Reduced
7
Closed
6
Top Buys
| 1 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
+$3.23M |
| 2 |
OCRX
Ocera Therapeutics, Inc.
OCRX
|
+$2.97M |
| 3 |
AERI
Aerie Pharmaceuticals
AERI
|
+$2.87M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$1.54M |
| 5 |
Neurocrine Biosciences
NBIX
|
+$989K |
Top Sells
| 1 |
AMPE
Ampio Pharmaceuticals Inc.
AMPE
|
+$7.02M |
| 2 |
VXRT
Vaxart
VXRT
|
+$2.08M |
| 3 |
Arcturus Therapeutics
ARCT
|
+$1.47M |
| 4 |
KERX
Keryx Biopharmaceuticals Inc
KERX
|
+$1.42M |
| 5 |
Galmed Pharmaceuticals
GLMD
|
+$677K |
Sector Composition
| 1 | Healthcare | 55.76% |
| 2 | Financials | 1.1% |
Similar funds
FGWP
STCG
SCP
CAAM
AWM
HCM
CPW
DWML